March 2021

IDIBELL researchers identify three clinical profiles of patients with COVID-19 with prognostic implications

A study published in The Lancet Infectious Diseases, in which Bellvitge University Hospital (HUB) and the Bellvitge Biomedical Research Institute (IDIBELL) have participated, has identified three phenotypes (clinical profiles or forms of patient presentation) of COVID-19, each with a different mortality.

Cervical cancer, cancer that we can eliminate

A study of the IDIBELL and ICO team on infections and cancer, in collaboration with WHO and UNICEF, has analyzed the rate of vaccinations around the world. They found that, while there is still a long way and many challenges ahead, there are a few countries that have already achieved it. Therefore it is an acceptable goal.

Xavier Bosch: “If a person has doubts about whether they should be vaccinated, what we have to do is resolve these doubts”

We spoke with Dr. Xavier Bosch, principal investigator of the IDIBELL infection and cancer research group, doctor at the ICO, professor at the UOC, and expert in the vaccine against HPV (human papillomavirus), on the challenge of large-scale vaccination against COVID-19 and the reticence that this whole process is generating.

Scroll to Top